José Miguel Lizcano

10PUBLICATIONS
57CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Peripheral nervous systemInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 03, 2023
MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists.

Sergio Espinosa-Gil, Saska Ivanova, Elisenda Alari-Pahissa

|Sep 19, 2022
The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.

Nora Diéguez-Martínez, Sergio Espinosa-Gil, Guillermo Yoldi

|Jul 09, 2022
Methuosis Contributes to Jaspine-B-Induced Cell Death.

Núria Bielsa, Mireia Casasampere, Jose Luis Abad

|Mar 16, 2022
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple-negative breast cancer models.

Emma Polonio-Alcalá, Sònia Solé-Sánchez, Pau Muñoz-Guardiola

|Aug 27, 2021
GRP78 Overexpression Triggers PINK1-IP<sub>3</sub>R-Mediated Neuroprotective Mitophagy.

Tatiana Leiva-Rodríguez, David Romeo-Guitart, Mireia Herrando-Grabulosa

|Sep 18, 2020
The antitumour drug ABTL0812 impairs neuroblastoma growth through endoplasmic reticulum stress-mediated autophagy and apoptosis.

Laia París-Coderch, Aroa Soriano, Carlos Jiménez

Pageof 2